Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What next after infliximab?
Baidoo L, Lichtenstein GR. Baidoo L, et al. Am J Gastroenterol. 2005 Jan;100(1):80-3. doi: 10.1111/j.1572-0241.2005.41716.x. Am J Gastroenterol. 2005. PMID: 15654785
Infliximab prevents Crohn's disease recurrence after ileal resection.
Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Regueiro M, et al. Among authors: baidoo l. Gastroenterology. 2009 Feb;136(2):441-50.e1; quiz 716. doi: 10.1053/j.gastro.2008.10.051. Epub 2008 Oct 31. Gastroenterology. 2009. PMID: 19109962 Clinical Trial.
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Siegel CA. Melmed GY, et al. Among authors: baidoo l. Clin Gastroenterol Hepatol. 2010 Aug;8(8):655-9. doi: 10.1016/j.cgh.2010.04.023. Epub 2010 May 6. Clin Gastroenterol Hepatol. 2010. PMID: 20451665
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials.
Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA. Jones JL, et al. Among authors: baidoo l. Clin Gastroenterol Hepatol. 2015 Dec;13(13):2233-40.e1-2; quiz e177-8. doi: 10.1016/j.cgh.2015.06.034. Epub 2015 Jun 30. Clin Gastroenterol Hepatol. 2015. PMID: 26142167 Review.
Reply: To PMID 24530602.
Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Regueiro M, et al. Among authors: baidoo l. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1407. doi: 10.1016/j.cgh.2014.03.002. Epub 2014 Mar 12. Clin Gastroenterol Hepatol. 2014. PMID: 24614332 No abstract available.
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA. Melmed GY, et al. Among authors: baidoo l. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1302-9. doi: 10.1016/j.cgh.2016.05.010. Epub 2016 May 14. Clin Gastroenterol Hepatol. 2016. PMID: 27189916
Reply: To PMID 24440221.
Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Regueiro M, et al. Among authors: baidoo l. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1764-5. doi: 10.1016/j.cgh.2014.06.015. Epub 2014 Jun 20. Clin Gastroenterol Hepatol. 2014. PMID: 24956081 No abstract available.
59 results